Dr. Christopher Reilly is an adult hematologist hematologist: (hee-muh-TOL-uh-jist) A doctor who specializes in treating blood diseases and disorders of blood producing organs. /oncologist and translational-clinical investigator at Dana-Farber Cancer Institute, specializing in the genetics, biology, and clinical management of hematologic malignancies. His work focuses on the role of inherited genetic variation in blood cancers, with particular emphasis on telomere telomere: A telomere is the end of a chromosome. Telomeres are made of repetitive sequences of non-coding DNA that protect the chromosome from damage. Each time a cell divides, the telomeres become shorter. EVvntually, the telomeres become so short that the cell can no longer divide. biology disorders and germline predisposition syndromes.
He leads the Dana-Farber Multidisciplinary Telomere Biology Disorder Program (Tier 1 Center of Excellence) and the Germline Predisposition to Bone Marrow Failure Bone Marrow Failure: A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be… and Leukemia Program, where he integrates clinical care with research to advance diagnosis, risk stratification, and treatment. His research aims to define the biological mechanisms linking germline variation to disease progression and to translate these insights into improved outcomes for patients.
boston, MA 02215
United States